Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

21.

Treating prediabetes in the obese: are GLP-1 analogues the answer?

Lancet.
Farr OM, Mantzoros CS.
| Apr 08, 2017
22.

A declaration to the UN on wars in the Middle East.

Lancet.
Burkle FM, Erickson TB, von Schreeb J, Redmond AD, Kayden S, Van Rooyen M.
| Feb 18, 2017
23.

Early goal-directed mobilisation after surgery - Authors' reply.

Lancet.
Eikermann M, Schaller SJ, Kasotakis G, Anstey M, Houle T.
| Feb 18, 2017
24.

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.

Lancet.
Cameron D, Piccart-Gebhart MJ, Gelber RD, Procter M, Goldhirsch A, de Azambuja E, Castro G, Untch M, Smith I, Gianni L, Baselga J, Al-Sakaff N, Lauer S, McFadden E, Leyland-Jones B, Bell R, Dowsett M, Jackisch C.
| Mar 25, 2017
25.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Lancet.
Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK.
| Feb 25, 2017
26.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lancet.
Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin Lavialle S, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O.
| 02 11, 2017
27.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

Lancet.
El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ.
| Jan 28, 2017
28.

Filgotinib for Crohn's disease-expanding treatment options.

Lancet.
Ananthakrishnan AN.
| Jan 21, 2017
29.

Shelf life considerations as EpiPen price increases.

Lancet.
Bartenstein DW, Diven DG.
| Dec 10, 2016
30.

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

Lancet.
Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, Dawson NA, van der Heijden MS, Dreicer R, Srinivas S, Retz MM, Joseph RW, Drakaki A, Vaishampayan UN, Sridhar SS, Quinn DI, Durán I, Shaffer DR, Eigl BJ, Grivas PD, Yu EY, Li S, Kadel EE, Boyd Z, Bourgon R, Hegde PS, Mariathasan S, Thåström A, Abidoye OO, Fine GD, Bajorin DF.
| 01 07, 2017
31.

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.

Lancet.
Teerlink JR, Felker GM, McMurray JJ, Solomon SD, Adams KF, Cleland JG, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcsányi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI, Honarpour N.
| Dec 10, 2016
32.

Ménière's disease: damaged hearing but reduced vertigo.

Lancet.
Rauch SD.
| Dec 03, 2016
33.

The post-Ebola baby boom: time to strengthen health systems.

Lancet.
McBain RK, Wickett E, Mugunga JC, Beste J, Konwloh P, Mukherjee J.
| 11 12, 2016
34.

Essential medicines for universal health coverage.

Lancet.
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR.
| Jan 28, 2017
35.

The ABC risk score for patients with atrial fibrillation.

Lancet.
Charidimou A.
| Oct 22, 2016
36.

The map is not the territory: medical records and 21st century practice.

Lancet.
Martin SA, Sinsky CA.
| Oct 22, 2016
37.

Early childhood development coming of age: science through the life course.

Lancet.
Black MM, Walker SP, Fernald LCH, Andersen CT, DiGirolamo AM, Lu C, McCoy DC, Fink G, Shawar YR, Shiffman J, Devercelli AE, Wodon QT, Vargas-Barón E, Grantham-McGregor S.
| 01 07, 2017
38.

Investing in the foundation of sustainable development: pathways to scale up for early childhood development.

Lancet.
Richter LM, Daelmans B, Lombardi J, Heymann J, Boo FL, Behrman JR, Lu C, Lucas JE, Perez-Escamilla R, Dua T, Bhutta ZA, Stenberg K, Gertler P, Darmstadt GL.
| 01 07, 2017
39.

Expanding the evidence base to drive more productive early childhood investment.

Lancet.
Shonkoff JP, Radner JM, Foote N.
| 01 07, 2017
40.

The metabolic stress response to burn trauma: current understanding and therapies.

Lancet.
Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN.
| Oct 01, 2016